acne%20vulgaris
ACNE VULGARIS
Acne vulgaris is a chronic inflammatory dermatosis which is notable for open and/or closed comedones (blackheads and whiteheads) and inflammatory lesions including papules, pustules or nodules.
Mild acne has <20 comedones or <15 inflammatory lesions or <30 total lesion count.
Moderate acne has 20-100 comedones or 15-20 inflammatory lesions or 30-125 total lesion count.
Severe papules/pustules or nodulocystic acne is the acne resistant to topical treatment or if scarring/nodular lesions are present.

Acne%20vulgaris Patient Education

Patient Education

  • Good communication between clinician and patient is important
    • Noncompliance is the most common cause of treatment failure
    • Adolescents may be sensitive to actual or supposed lack of acceptance on the part of their physicians
    • By giving the patient clear guidelines and realistic expectations, noncompliance can be avoided
  • Patient should be made aware that treatment will control acne, not cure it
    • Many acne sufferers expect to be disappointed with the results of treatment
    • Long-term therapy is required to control lesions
    • Acne tends to be less active as age increases
  • Let patient know that acne medication will take up to 8-12 weeks to work and there is no "quick-fix"

Diet and Acne

  • No specific recommendations are available for the correlation of diet and acne severity, therefore patients advise should be individualized
  • Several studies have suggested that food with high glycemic content and dairy may be associated with acne
  • Further studies are needed to conclude the association of diet to acne severity
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.